TITLE

FDA Actions

AUTHOR(S)
Elliott, William T.
PUB. DATE
December 2007
SOURCE
Travel Medicine Advisor;Dec2007, Vol. 17 Issue 12, p2
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the warnings issued by the U.S. Food and Drug Administration (FDA) regarding the association between hearing loss and the use of phosphodiesterase type 5 inhibitors. The FDA cautioned consumers about the use of the drug modafinil. Restriction of childhood cold medications to children is recommended by the FDA advisory panel.
ACCESSION #
27897543

 

Related Articles

  • FDA Actions.  // Neurology Alert;Dec2007, Vol. 26 Issue 4, p2 

    The article reports on warnings announced by the U.S. Food and Drug Administration (FDA) about phosphodiesterase type 5 inhibitors regarding hearing loss. It mentions that modafinil has also been the subject of warnings, as it is associated with severe rashes. The agency has acclaimed strong...

  • FDA Actions. Elliott, William T. // Clinical Oncology Alert;Dec2007 Pharmacology Watch, p2 

    The article presents the warnings from the U.S. Food and Drug Administration (FDA) regarding the use of phosphodiesterase type 5 inhibitors for treating hearing loss. Among the drugs which are the subject of FDA warnings are sildenafil, tadalafil, vardenafil and modafinil. An FDA advisory panel...

  • FDA Actions. Elliott, William T. // Primary Care Reports;Dec2007, Vol. 13 Issue 12, p2 

    The article presents an update on activities of the U.S. Food and Drug Administration (FDA). The agency announced warnings on phosphodiesterase type 5 inhibitors regarding hearing loss. It has also recommended restricting childhood cold medications to children over the age of six years....

  • Stronger warning for ED drugs.  // Pharmaceutical Representative;Dec2007, Vol. 37 Issue 12, p16 

    The article reports that the U.S. Food and Drug Administration (FDA) has approved the new labeling for a class of erectile dysfunction therapies. The new label highlights the potential risk of sudden hearing loss associated with the drug. The class is known as phosphodiesterase type 5...

  • FDA Actions.  // Clinical Cardiology Alert;Dec2007, Vol. 26 Issue 12, p2 

    The article reports that the U.S. Food and Drug Administration (FDA) has issued new warnings concerning the adverse health effects of phosphodiesterase type inhibitors. It mentions that the agency has received 29 cases of sudden hearing loss associated with inhibitors like sildenafil, tadalafil...

  • FDA Actions.  // Clinical Cardiology Alert;Dec2007 Pharmacology Watch, p2 

    The article reports on actions of the U.S. Food & Drug Administration (FDA). The FDA announced that temporary hearing loss can be experienced by men taking phosphodiesterase type 5 inhibitors such as sildenafil and tadalafil. Modafinil was found to have the potential to cause rashes and...

  • FDA Actions.  // Clinical Oncology Alert;Dec2007, Vol. 23 Issue 12, p2 

    The article reports on drug-related actions taken by the U.S. Food and Drug Administration (FDA) as of December 2007. The agency has announced new warnings on phosphodiesterase type 5 inhibitors about hearing loss. The agency suggested caution should be exercised when modafinil is administered...

  • UC San Francisco Begins Clinical Trials of Bionic Ear for Profoundly Deaf Adults.  // Ascribe Newswire: Health;6/7/2001, p1 

    Researchers at San Francisco, California-based University of California (UCSF) Department of Otolaryngology-Head and Neck Surgery will begin clinical trials this month of the Clarion CII Bionic Ear cochlear implant to help adults with profound hearing loss to hear again. The UCSF Douglas Grant...

  • Can Viagra Make You Deaf? GANDELMAN, JOE // Moderate Voice;5/19/2011, p3 

    The article reports on the question whether Viagra has the possibility to make one deaf. It mentions that researchers have found evidence that Viagra and anti-impotence drugs can result to hearing impairment. It notes that the U.S. Food and Drug Administration (FDA) has given warning since 1997...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics